Kevin Tran
Optometrist · Rancho Cucamonga, CANPI 1710030911
Payments from drug & device makers
Across 105 payments — averaging $41.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch & Lomb Americas Inc.$1K
- Tarsus Pharmaceuticals, Inc.$640
- Dompe US, Inc.$366
- Amgen$322
- Kala Pharmaceuticals, Inc.$268
- Sun Pharmaceutical Industries Inc.$251
- plus $1K from 13 others
What the payments were for
- Food & beverage$4,324100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch & Lomb Americas Inc. | 26 | $1,047 |
| Tarsus Pharmaceuticals, Inc. | 16 | $640 |
| Dompe US, Inc. | 5 | $366 |
| Amgen | 13 | $322 |
| Kala Pharmaceuticals, Inc. | 3 | $268 |
| Sun Pharmaceutical Industries Inc. | 5 | $251 |
| Aerie Pharmaceuticals, Inc. | 5 | $178 |
| Alcon | 5 | $163 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 2 | $155 |
| Astellas Pharma US Inc | 1 | $147 |
| Harrow Eye, LLC | 5 | $143 |
| Glaukos Corporation | 1 | $132 |
| Shire North American Group Inc | 2 | $132 |
| Novartis | 7 | $110 |
| Carl Zeiss Meditec, Inc. | 1 | $68 |
| AbbVie(2 entities) | 3 | $62 |
| Oyster Point Pharma, Inc. | 3 | $61 |
| Genentech USA, Inc. | 1 | $59 |
| Thea Pharma Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MIEBO$626
- XIIDRA$614
- Rhopressa$225
- Rocklatan$225
- Oxervate$223
- Photrexa Viscous and Photrexa$132
- KXL System$132
- EYSUVIS$125
- VYZULTA$125
- INVELTYS$124
- XDEMVY$124
- CEQUA$123
- TEPEZZA$114
- ALDEN SCLERAL ZENLENS$107
How this compares
$4,324 in reported general payments places this provider in the 90th percentile of 6,778 optometrist providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 246 | $189,392 |
| XiidraLifitegrast | 122 | $101,627 |
| Cyclosporine | 205 | $86,593 |
| CequaCyclosporine | 43 | $36,721 |
| LumiganBimatoprost | 80 | $29,817 |
| RhopressaNetarsudil Mesylate | 38 | $22,329 |
| RocklatanNetarsudil Mesylat/Latanoprost | 44 | $20,690 |
| Latanoprost | 1,873 | $20,381 |
| Alphagan PBrimonidine Tartrate | 65 | $16,425 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 100 | $16,157 |
| MieboPerfluorohexyloctane/Pf | 16 | $11,472 |
| Brimonidine Tartrate | 446 | $10,958 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 451 | $8,495 |
| VyzultaLatanoprostene Bunod | 18 | $5,940 |
| CombiganBrimonidine Tartrate/Timolol | 13 | $5,880 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis, Lumigan, Alphagan P, Combigan | $62 | $241,514404 claims |
| Bausch & Lomb Americas Inc.Xiidra, Miebo, Vyzulta | $1,047 | $119,039156 claims |
| Aerie Pharmaceuticals, Inc.Rhopressa, Rocklatan | $178 | $43,01882 claims |
| Sun Pharmaceutical Industries Inc.Cequa | $251 | $36,72143 claims |
| AlconSimbrinza | $163 | $3,65014 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,778 optometrist providers in California.
Other optometrist in Rancho Cucamonga
- Meng LinBerkeley$6.9M
- Steve YoelinNewport Beach$6.1M
- Matthew GellerSpring Valley$3.5M
- David Kasanoffla Mesa$1M
- Colton HeinrichFullerton$987K
- Elsa PaoOakland$910K
- Keith WanSan Diego$887K
- Selena ChanSan Francisco$677K
- Melissa EricksonDavis$522K
- Omid KhodaiLake Forest$499K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.